ACETAMINOPHEN, ASPIRIN, AND CAFFEINE

ACETAMINOPHEN, ASPIRIN, AND CAFFEINE was reported 21130 times

ACETAMINOPHEN, ASPIRIN, AND CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRACRANIAL VENOUS SINUS STENOSIS 7 0.3889
1 MEDICATION OVERUSE HEADACHE 201 0.2348
2 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3315 0.1131
3 POSTNATAL GROWTH RESTRICTION 10 0.0763
4 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 16 0.0675
5 DRUG EFFECT VARIABLE 64 0.0565
6 OPTIC DISC HAEMORRHAGE 8 0.0349
7 EMERGENCY CARE EXAMINATION 23 0.0339
8 DRUG EFFECT FASTER THAN EXPECTED 9 0.0270
9 PRODUCT USED FOR UNKNOWN INDICATION 28 0.0222
10 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 10 0.0200
11 THERAPEUTIC PRODUCT EFFECT VARIABLE 73 0.0188
12 NO ADVERSE DRUG EFFECT 12 0.0177
13 PRODUCT USE IN UNAPPROVED INDICATION 3858 0.0156
14 GALLBLADDER CHOLESTEROLOSIS 7 0.0154
15 FOREIGN BODY TRAUMA 11 0.0150
16 ULCER HAEMORRHAGE 88 0.0130
17 AMPHETAMINES POSITIVE 8 0.0107
18 PRE-EXISTING CONDITION IMPROVED 65 0.0104
19 THERAPEUTIC RESPONSE UNEXPECTED 447 0.0100
20 STOMACH DISCOMFORT 49 0.0095
21 DRUG EFFECT LESS THAN EXPECTED 140 0.0094
22 CHOLECYSTITIS CHRONIC 63 0.0094
23 FEELING JITTERY 174 0.0091
24 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18 0.0091
25 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
26 BILIARY DYSKINESIA 14 0.0082
27 CLUSTER HEADACHE 11 0.0080
28 GASTRIC PERFORATION 21 0.0077
29 PRETERM PREMATURE RUPTURE OF MEMBRANES 9 0.0075
30 EXPIRED DRUG ADMINISTERED 37 0.0075
31 GASTRIC ULCER 138 0.0073
32 GALLBLADDER INJURY 14 0.0072
33 GASTRIC ULCER PERFORATION 9 0.0071
34 ULCER 111 0.0070
35 MIGRAINE 657 0.0069
36 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 46 0.0068
37 CATAPLEXY 9 0.0064
38 GASTRIC ULCER HAEMORRHAGE 33 0.0059
39 INTENTIONAL MISUSE 11 0.0058
40 INCORRECT DRUG ADMINISTRATION DURATION 156 0.0055
41 DRUG ABUSER 34 0.0055
42 INCORRECT DOSAGE ADMINISTERED 27 0.0055
43 SLEEP PARALYSIS 8 0.0054
44 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 298 0.0054
45 GASTROINTESTINAL ULCER 12 0.0054
46 PRODUCT PACKAGE ASSOCIATED INJURY 12 0.0054
47 EPIGASTRIC DISCOMFORT 21 0.0054
48 GASTRIC HAEMORRHAGE 61 0.0053
49 SNORING 20 0.0053
50 MIGRAINE WITH AURA 14 0.0051
51 THERAPEUTIC PRODUCT EFFECT DELAYED 23 0.0050
52 PRODUCT ADMINISTRATION INTERRUPTED 39 0.0050
53 REBOUND ACID HYPERSECRETION 15 0.0050
54 ACCIDENTAL EXPOSURE 20 0.0048
55 GASTRITIS EROSIVE 22 0.0047
56 SPONDYLOLISTHESIS 8 0.0046
57 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 33 0.0046
58 SINUS HEADACHE 27 0.0045
59 IDIOPATHIC INTRACRANIAL HYPERTENSION 10 0.0044
60 ESSENTIAL HYPERTENSION 8 0.0044
61 SINUS PAIN 10 0.0043
62 GASTRIC DISORDER 144 0.0042
63 INFUSION SITE BRUISING 9 0.0042
64 ACUTE SINUSITIS 7 0.0041
65 FOREIGN BODY 16 0.0040
66 INFUSION SITE DISCHARGE 7 0.0040
67 PEPTIC ULCER 13 0.0039
68 PRODUCT TAMPERING 7 0.0039
69 INFUSION SITE PRURITUS 12 0.0038
70 AURA 7 0.0037
71 DRUG EFFECT DELAYED 17 0.0037
72 SLEEP APNOEA SYNDROME 71 0.0037
73 PARANASAL SINUS DISCOMFORT 14 0.0037
74 HANGOVER 13 0.0037
75 FACE INJURY 14 0.0037
76 SOMNAMBULISM 24 0.0037
77 DRUG SCREEN FALSE POSITIVE 10 0.0036
78 DRUG SCREEN POSITIVE 28 0.0035
79 SEASONAL ALLERGY 50 0.0035
80 DUODENAL ULCER HAEMORRHAGE 10 0.0035
81 UNDERDOSE 254 0.0035
82 THERAPEUTIC RESPONSE CHANGED 22 0.0035
83 EXPIRED PRODUCT ADMINISTERED 115 0.0035
84 AUTOIMMUNE THYROIDITIS 13 0.0034
85 TEMPOROMANDIBULAR JOINT SYNDROME 9 0.0034
86 FEELING DRUNK 25 0.0034
87 PREMATURE LABOUR 19 0.0034
88 INTERVERTEBRAL DISC DISORDER 14 0.0033
89 DRUG ADMINISTRATION ERROR 100 0.0033
90 NEPHROGENIC ANAEMIA 15 0.0032
91 HYPERACUSIS 12 0.0032
92 HYPERPARATHYROIDISM SECONDARY 8 0.0032
93 PRODUCT COMPLAINT 80 0.0032
94 CONTRAINDICATED PRODUCT ADMINISTERED 95 0.0031
95 HYPERTONIC BLADDER 9 0.0031
96 BILIARY COLIC 9 0.0031
97 MULTIPLE ALLERGIES 24 0.0031
98 DRUG INEFFECTIVE 4027 0.0031
99 TENSION HEADACHE 13 0.0030
100 INITIAL INSOMNIA 31 0.0030
101 MEDICATION ERROR 166 0.0030
102 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 211 0.0030
103 GESTATIONAL DIABETES 14 0.0029
104 CHRONIC SINUSITIS 11 0.0029
105 POOR QUALITY SLEEP 63 0.0029
106 FIBROMYALGIA 71 0.0029
107 CHOLELITHIASIS 95 0.0029
108 TACHYPHRENIA 10 0.0029
109 OESOPHAGEAL ULCER 11 0.0029
110 OESOPHAGEAL DISORDER 11 0.0029
111 INFUSION SITE ERYTHEMA 24 0.0028
112 POST-TRAUMATIC STRESS DISORDER 19 0.0028
113 BLADDER PAIN 9 0.0028
114 DEVICE INFUSION ISSUE 7 0.0028
115 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
116 GALLBLADDER DISORDER 49 0.0027
117 ABDOMINAL PAIN UPPER 564 0.0027
118 ABDOMINAL DISCOMFORT 459 0.0027
119 DRUG EFFECT INCOMPLETE 99 0.0027
120 INFUSION SITE SWELLING 17 0.0027
121 VITAMIN D DEFICIENCY 26 0.0027
122 PAPILLOEDEMA 12 0.0027
123 CONCOMITANT DISEASE AGGRAVATED 16 0.0026
124 CONCUSSION 20 0.0026
125 SINUS DISORDER 51 0.0026
126 DECREASED INTEREST 15 0.0025
127 EUPHORIC MOOD 26 0.0025
128 SUSPECTED COUNTERFEIT PRODUCT 10 0.0025
129 PRODUCT QUALITY ISSUE 342 0.0025
130 EXTRA DOSE ADMINISTERED 101 0.0025
131 DRUG TOLERANCE DECREASED 7 0.0025
132 INTENTIONAL DRUG MISUSE 52 0.0025
133 INFUSION SITE PAIN 32 0.0025
134 REBOUND EFFECT 28 0.0025
135 SPONDYLITIS 9 0.0025
136 WHEELCHAIR USER 11 0.0025
137 TENSION 15 0.0025
138 MENINGITIS ASEPTIC 11 0.0024
139 COELIAC DISEASE 24 0.0024
140 DYSPEPSIA 239 0.0024
141 SCOLIOSIS 15 0.0024
142 MATERNAL EXPOSURE TIMING UNSPECIFIED 9 0.0024
143 HIATUS HERNIA 31 0.0024
144 SPINAL OSTEOARTHRITIS 21 0.0024
145 URINE ODOUR ABNORMAL 14 0.0024
146 ENERGY INCREASED 14 0.0024
147 DERMATITIS CONTACT 27 0.0024
148 INTERVERTEBRAL DISC PROTRUSION 51 0.0023
149 INCORRECT DOSE ADMINISTERED 532 0.0023
150 PHOTOPHOBIA 43 0.0023
151 MUSCLE TIGHTNESS 37 0.0023
152 NERVOUSNESS 119 0.0023
153 PAROSMIA 17 0.0023
154 WRIST FRACTURE 27 0.0023
155 INTRACRANIAL ANEURYSM 9 0.0022
156 LACERATION 21 0.0022
157 SPINAL FUSION SURGERY 9 0.0022
158 ANEURYSM 11 0.0022
159 BACK INJURY 24 0.0022
160 MUSCLE STRAIN 19 0.0022
161 MICTURITION URGENCY 25 0.0022
162 DRUG TOLERANCE 11 0.0022
163 SYNOVIAL CYST 10 0.0022
164 CARDIAC FLUTTER 14 0.0022
165 HEADACHE 1357 0.0022
166 NERVE INJURY 24 0.0022
167 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
168 FEELING OF DESPAIR 10 0.0021
169 INFUSION SITE HAEMORRHAGE 7 0.0021
170 DRUG DEPENDENCE 341 0.0021
171 SPINAL COLUMN STENOSIS 10 0.0021
172 VITAMIN D DECREASED 18 0.0021
173 PARANASAL SINUS HYPERSECRETION 8 0.0021
174 OVERDOSE 451 0.0021
175 TOOTH INJURY 9 0.0021
176 ACTIVITIES OF DAILY LIVING IMPAIRED 41 0.0021
177 TINNITUS 95 0.0021
178 HEPATIC CYST 7 0.0021
179 PHOTOPSIA 13 0.0021
180 ROAD TRAFFIC ACCIDENT 86 0.0021
181 IMPAIRED DRIVING ABILITY 23 0.0020
182 BLADDER DISORDER 20 0.0020
183 ANAL INCONTINENCE 18 0.0020
184 OVARIAN CYST 20 0.0020
185 DENTAL CARIES 22 0.0020
186 SENSORY LOSS 16 0.0020
187 ENURESIS 8 0.0020
188 END STAGE RENAL DISEASE 36 0.0020
189 RETCHING 42 0.0020
190 INSOMNIA 524 0.0020
191 BOWEL MOVEMENT IRREGULARITY 15 0.0020
192 INCORRECT PRODUCT ADMINISTRATION DURATION 42 0.0019
193 FEELING ABNORMAL 461 0.0019
194 LIVE BIRTH 16 0.0019
195 FOOD INTOLERANCE 7 0.0019
196 TOOTH FRACTURE 21 0.0019
197 FACIAL PAIN 17 0.0019
198 INSURANCE ISSUE 29 0.0019
199 FAECES DISCOLOURED 41 0.0019
200 SCIATICA 30 0.0019
201 FORMICATION 13 0.0019
202 PANIC ATTACK 68 0.0019
203 BRUXISM 10 0.0019
204 HAEMATEMESIS 47 0.0019
205 PALPITATIONS 217 0.0019
206 BRAIN NEOPLASM 17 0.0018
207 CHOLECYSTITIS 22 0.0018
208 GASTROOESOPHAGEAL REFLUX DISEASE 148 0.0018
209 COMMUNICATION DISORDER 7 0.0018
210 CHRONIC KIDNEY DISEASE 139 0.0018
211 HAEMORRHAGIC ANAEMIA 8 0.0018
212 CHOKING SENSATION 10 0.0018
213 ABDOMINAL TENDERNESS 9 0.0018
214 SCAR 31 0.0018
215 PARAESTHESIA ORAL 26 0.0018
216 HUNGER 25 0.0018
217 MENISCUS INJURY 11 0.0018
218 BREAST MASS 12 0.0018
219 PRODUCT USE COMPLAINT 28 0.0018
220 SINUSITIS 181 0.0018
221 PHARYNGEAL OEDEMA 27 0.0018
222 EXOSTOSIS 16 0.0018
223 BIPOLAR DISORDER 19 0.0017
224 BLEPHAROSPASM 11 0.0017
225 NEPHROLITHIASIS 80 0.0017
226 HYSTERECTOMY 15 0.0017
227 GASTROINTESTINAL PAIN 19 0.0017
228 IRRITABLE BOWEL SYNDROME 37 0.0017
229 SKIN WARM 10 0.0017
230 GASTRITIS 45 0.0017
231 SELF-MEDICATION 7 0.0017
232 HYPERURICAEMIA 7 0.0017
233 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 121 0.0017
234 PRODUCT USE ISSUE 319 0.0017
235 CHOKING 33 0.0017
236 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
237 SPINAL DISORDER 16 0.0017
238 PRE-ECLAMPSIA 8 0.0017
239 WALKING AID USER 11 0.0017
240 EYE SWELLING 62 0.0017
241 HEART RATE INCREASED 165 0.0017
242 HIP SURGERY 9 0.0017
243 PANIC REACTION 12 0.0017
244 GASTROENTERITIS VIRAL 30 0.0017
245 ATELECTASIS 16 0.0017
246 ORAL DISCOMFORT 23 0.0017
247 ARTHRITIS 129 0.0016
248 TENDERNESS 17 0.0016
249 SINUS CONGESTION 22 0.0016
250 IRON DEFICIENCY ANAEMIA 15 0.0016
251 APPLICATION SITE BURN 8 0.0016
252 PAIN IN JAW 46 0.0016
253 LIMB INJURY 44 0.0016
254 STREPTOCOCCAL INFECTION 9 0.0016
255 CYST 20 0.0016
256 NECK PAIN 90 0.0016
257 RENAL PAIN 17 0.0016
258 TOOTHACHE 29 0.0016
259 BLOOD IRON DECREASED 19 0.0016
260 DIVERTICULUM INTESTINAL 7 0.0016
261 BACK DISORDER 26 0.0016
262 RESTLESS LEGS SYNDROME 29 0.0016
263 PRODUCT PHYSICAL ISSUE 32 0.0016
264 DIVERTICULUM 11 0.0015
265 JOINT INJURY 33 0.0015
266 NAUSEA 1213 0.0015
267 HEPATOMEGALY 15 0.0015
268 HEAD DISCOMFORT 27 0.0015
269 INCREASED TENDENCY TO BRUISE 14 0.0015
270 LOCALISED OEDEMA 7 0.0015
271 BLOOD MAGNESIUM DECREASED 13 0.0015
272 PHARYNGOLARYNGEAL PAIN 8 0.0015
273 MIDDLE INSOMNIA 28 0.0015
274 LOSS OF CONSCIOUSNESS 192 0.0015
275 INTENTIONAL PRODUCT MISUSE 131 0.0015
276 THYROID DISORDER 23 0.0015
277 HEREDITARY ANGIOEDEMA 16 0.0015
278 CHOLECYSTECTOMY 17 0.0015
279 WRONG TECHNIQUE IN DRUG USAGE PROCESS 54 0.0015
280 COLITIS ISCHAEMIC 10 0.0015
281 ROTATOR CUFF SYNDROME 19 0.0015
282 PRODUCT LABEL ISSUE 10 0.0015
283 HYPOAESTHESIA 220 0.0015
284 HYDROCEPHALUS 8 0.0015
285 IMPAIRED GASTRIC EMPTYING 20 0.0015
286 EAR INFECTION 39 0.0015
287 SPINAL OPERATION 18 0.0015
288 HYPOAESTHESIA ORAL 22 0.0015
289 ECCHYMOSIS 10 0.0015
290 FAECAL INCONTINENCE 7 0.0015
291 HEAD INJURY 46 0.0015
292 TREMOR 241 0.0015
293 ANXIETY 411 0.0014
294 LIP SWELLING 48 0.0014
295 DISSOCIATION 11 0.0014
296 DYSMENORRHOEA 19 0.0014
297 CARPAL TUNNEL SYNDROME 20 0.0014
298 KIDNEY INFECTION 28 0.0014
299 ACCIDENT 17 0.0014
300 INJURY 100 0.0014
301 INCONTINENCE 15 0.0014
302 JOINT DISLOCATION 15 0.0014
303 CHROMATURIA 32 0.0014
304 FOOT OPERATION 7 0.0014
305 SWELLING FACE 92 0.0014
306 CHOLECYSTITIS ACUTE 8 0.0014
307 DIZZINESS 702 0.0014
308 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 283 0.0014
309 HYPERSOMNIA 40 0.0014
310 BLOOD CHOLESTEROL INCREASED 65 0.0014
311 EAR PAIN 27 0.0014
312 NASAL DISCOMFORT 11 0.0014
313 DISEASE RECURRENCE 66 0.0014
314 PHARYNGITIS STREPTOCOCCAL 15 0.0014
315 HAEMORRHOIDS 27 0.0014
316 PERIPHERAL COLDNESS 19 0.0014
317 SOMNOLENCE 278 0.0014
318 HYPERVENTILATION 8 0.0014
319 TOOTH INFECTION 18 0.0014
320 BRONCHITIS 101 0.0014
321 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 46 0.0014
322 RIB FRACTURE 28 0.0014
323 MUSCLE DISORDER 11 0.0014
324 TOOTH DISORDER 30 0.0013
325 PREGNANCY 27 0.0013
326 CONTUSION 129 0.0013
327 EXPOSURE DURING PREGNANCY 82 0.0013
328 FOOT FRACTURE 25 0.0013
329 THROAT IRRITATION 59 0.0013
330 LIGAMENT SPRAIN 13 0.0013
331 VERTIGO 80 0.0013
332 IMPAIRED WORK ABILITY 28 0.0013
333 RESPIRATION ABNORMAL 9 0.0013
334 ABNORMAL DREAMS 36 0.0013
335 NERVE COMPRESSION 12 0.0013
336 DRUG EFFECT DECREASED 70 0.0013
337 LARGE INTESTINE PERFORATION 9 0.0013
338 THROAT TIGHTNESS 35 0.0013
339 BEDRIDDEN 17 0.0013
340 CRYING 47 0.0013
341 CHEST PAIN 239 0.0013
342 BLOOD PRESSURE INCREASED 197 0.0013
343 WITHDRAWAL SYNDROME 54 0.0013
344 FLANK PAIN 12 0.0013
345 HYPERTENSION 271 0.0013
346 CHEST DISCOMFORT 131 0.0013
347 MUSCULOSKELETAL DISCOMFORT 22 0.0013
348 TOOTH ABSCESS 13 0.0013
349 DUODENAL ULCER 9 0.0013
350 SLUGGISHNESS 13 0.0013
351 NIGHT SWEATS 41 0.0013
352 EAR DISCOMFORT 13 0.0013
353 COAGULOPATHY 21 0.0013
354 RENAL CYST 10 0.0013
355 TRICUSPID VALVE INCOMPETENCE 10 0.0013
356 ACCIDENTAL OVERDOSE 46 0.0013
357 VOMITING 590 0.0013
358 DEPRESSION 285 0.0013
359 ILLNESS 129 0.0013
360 HERNIA 24 0.0012
361 SPEECH DISORDER 65 0.0012
362 HEART RATE IRREGULAR 28 0.0012
363 UTERINE LEIOMYOMA 9 0.0012
364 AUTOIMMUNE DISORDER 12 0.0012
365 LIMB DISCOMFORT 38 0.0012
366 INTERNAL HAEMORRHAGE 14 0.0012
367 APHASIA 37 0.0012
368 LACRIMATION INCREASED 37 0.0012
369 MUSCULOSKELETAL PAIN 64 0.0012
370 HYPERAESTHESIA 10 0.0012
371 ORAL CANDIDIASIS 16 0.0012
372 BALANCE DISORDER 105 0.0012
373 ARTHROPOD BITE 9 0.0012
374 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
375 MENSTRUAL DISORDER 10 0.0012
376 HOT FLUSH 91 0.0012
377 RALES 7 0.0012
378 HYDRONEPHROSIS 9 0.0012
379 EYE HAEMORRHAGE 16 0.0012
380 LIVER DISORDER 53 0.0012
381 CYSTITIS 38 0.0012
382 PRESYNCOPE 29 0.0012
383 HYPOTHYROIDISM 38 0.0012
384 MEMORY IMPAIRMENT 163 0.0012
385 MULTIPLE SCLEROSIS RELAPSE 81 0.0012
386 URINARY INCONTINENCE 35 0.0012
387 BACK PAIN 274 0.0012
388 NEPHROPATHY 11 0.0012
389 OROPHARYNGEAL PAIN 109 0.0012
390 MACULAR DEGENERATION 14 0.0012
391 MENORRHAGIA 23 0.0012
392 RENAL FAILURE CHRONIC 9 0.0012
393 GOUT 21 0.0012
394 DYSPHAGIA 111 0.0012
395 BURNING SENSATION 82 0.0012
396 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
397 EYE MOVEMENT DISORDER 8 0.0012
398 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
399 DYSSTASIA 34 0.0012
400 BLOOD POTASSIUM DECREASED 35 0.0012
401 MUSCULOSKELETAL CHEST PAIN 18 0.0012
402 TEMPERATURE INTOLERANCE 12 0.0012
403 LYMPHOEDEMA 8 0.0012
404 NOCTURIA 14 0.0012
405 ILL-DEFINED DISORDER 70 0.0012
406 SKIN HAEMORRHAGE 17 0.0011
407 APHONIA 16 0.0011
408 EXTRASYSTOLES 8 0.0011
409 PRODUCT ODOUR ABNORMAL 12 0.0011
410 ARTERIAL OCCLUSIVE DISEASE 9 0.0011
411 MASS 16 0.0011
412 PARAESTHESIA 180 0.0011
413 INTENTIONAL PRODUCT USE ISSUE 100 0.0011
414 HAEMATOCHEZIA 63 0.0011
415 BLOOD CALCIUM INCREASED 10 0.0011
416 GROIN PAIN 10 0.0011
417 FLATULENCE 64 0.0011
418 THERMAL BURN 8 0.0011
419 POLLAKIURIA 47 0.0011
420 NASAL CONGESTION 66 0.0011
421 MULTIPLE INJURIES 7 0.0011
422 NEURALGIA 27 0.0011
423 HAEMATOCRIT DECREASED 22 0.0011
424 OSTEOARTHRITIS 47 0.0011
425 VISUAL FIELD DEFECT 8 0.0011
426 AMNESIA 72 0.0011
427 BLOOD URINE PRESENT 21 0.0011
428 THERAPEUTIC RESPONSE DECREASED 67 0.0011
429 DYSGEUSIA 82 0.0011
430 HYPOKINESIA 16 0.0011
431 SPINAL FRACTURE 22 0.0011
432 BONE DISORDER 20 0.0011
433 BRAIN INJURY 11 0.0011
434 MAJOR DEPRESSION 8 0.0011
435 ORAL DISORDER 8 0.0011
436 BLINDNESS TRANSIENT 8 0.0011
437 MUSCLE TWITCHING 25 0.0011
438 CONSTIPATION 236 0.0011
439 CEREBRAL DISORDER 8 0.0011
440 FEAR 29 0.0011
441 COLD SWEAT 19 0.0011
442 COORDINATION ABNORMAL 15 0.0011
443 RECTAL HAEMORRHAGE 46 0.0011
444 OCULAR DISCOMFORT 12 0.0011
445 SENSATION OF FOREIGN BODY 9 0.0011
446 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
447 PAIN 654 0.0011
448 EYE PAIN 60 0.0011
449 SENSORY DISTURBANCE 17 0.0011
450 EYE DISCHARGE 11 0.0011
451 CARDIOMEGALY 13 0.0011
452 APPETITE DISORDER 7 0.0011
453 HYPERHIDROSIS 136 0.0011
454 UPPER LIMB FRACTURE 21 0.0011
455 MULTIPLE SCLEROSIS 50 0.0010
456 MALIGNANT MELANOMA 14 0.0010
457 QUALITY OF LIFE DECREASED 14 0.0010
458 PROCEDURAL COMPLICATION 8 0.0010
459 LOWER LIMB FRACTURE 20 0.0010
460 CARDIAC MURMUR 9 0.0010
461 PRODUCT ADMINISTRATION ERROR 21 0.0010
462 RESTLESSNESS 38 0.0010
463 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
464 POSTOPERATIVE WOUND INFECTION 7 0.0010
465 FEEDING DISORDER 21 0.0010
466 LOCAL SWELLING 18 0.0010
467 DIZZINESS POSTURAL 10 0.0010
468 MALAISE 452 0.0010
469 RASH MACULAR 36 0.0010
470 BRAIN OEDEMA 13 0.0010
471 BODY HEIGHT DECREASED 11 0.0010
472 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
473 FALL 341 0.0010
474 SWOLLEN TONGUE 32 0.0010
475 SKIN DISCOLOURATION 47 0.0010
476 CROHN'S DISEASE 7 0.0010
477 DISTURBANCE IN ATTENTION 55 0.0010
478 DECREASED ACTIVITY 11 0.0010
479 MUSCLE SPASMS 187 0.0010
480 HYPERSENSITIVITY 189 0.0010
481 PRURITUS GENERALISED 22 0.0010
482 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
483 PRODUCT SUBSTITUTION ISSUE 58 0.0010
484 OESOPHAGITIS 11 0.0010
485 THROMBOSIS 81 0.0010
486 FEELING COLD 28 0.0010
487 ANGER 34 0.0010
488 VISION BLURRED 138 0.0010
489 SUICIDAL IDEATION 92 0.0010
490 GASTROINTESTINAL DISORDER 90 0.0010
491 UNEVALUABLE EVENT 76 0.0010
492 PULMONARY EMBOLISM 95 0.0010
493 DIABETES MELLITUS 76 0.0010
494 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
495 INFLUENZA LIKE ILLNESS 82 0.0010
496 PAPULE 7 0.0010
497 DYSPHONIA 58 0.0010
498 FATIGUE 771 0.0010
499 ECONOMIC PROBLEM 15 0.0010
500 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
501 ABDOMINAL PAIN LOWER 25 0.0010
502 OSTEOPENIA 15 0.0010
503 MENTAL DISORDER 43 0.0010
504 DRY THROAT 10 0.0010
505 POST PROCEDURAL INFECTION 8 0.0010
506 NIGHTMARE 34 0.0010
507 BLOOD CALCIUM DECREASED 11 0.0010
508 LIVER INJURY 24 0.0010
509 GRAND MAL CONVULSION 9 0.0010
510 DRY MOUTH 79 0.0010
511 PAIN IN EXTREMITY 286 0.0010
512 DEEP VEIN THROMBOSIS 63 0.0010
513 ANKLE FRACTURE 15 0.0010
514 TENDONITIS 15 0.0010
515 SPINAL COMPRESSION FRACTURE 8 0.0010
516 GAIT DISTURBANCE 185 0.0010
517 HEPATIC STEATOSIS 18 0.0010
518 THINKING ABNORMAL 18 0.0010
519 APPENDICITIS 9 0.0010
520 SLEEP DISORDER 68 0.0010
521 CONVULSION 55 0.0010
522 INTENTIONAL UNDERDOSE 7 0.0010
523 ABDOMINAL DISTENSION 100 0.0010
524 DEAFNESS 25 0.0010
525 BONE PAIN 56 0.0010
526 BLOOD PRESSURE ABNORMAL 19 0.0010
527 CHILLS 112 0.0010
528 ATRIAL SEPTAL DEFECT 8 0.0010
529 THIRST 17 0.0010
530 URTICARIA 159 0.0009
531 MUSCLE ATROPHY 12 0.0009
532 HYPOPHOSPHATAEMIA 7 0.0009
533 INJECTION SITE IRRITATION 12 0.0009
534 SURGERY 55 0.0009
535 POST PROCEDURAL COMPLICATION 18 0.0009
536 GLAUCOMA 18 0.0009
537 GASTROINTESTINAL HAEMORRHAGE 78 0.0009
538 IRRITABILITY 56 0.0009
539 ABASIA 23 0.0009
540 PRESCRIBED OVERDOSE 18 0.0009
541 PSYCHOLOGICAL TRAUMA 8 0.0009
542 ABDOMINAL PAIN 215 0.0009
543 EPISTAXIS 69 0.0009
544 CEREBRAL HAEMORRHAGE 33 0.0009
545 SKIN SWELLING 8 0.0009
546 BLINDNESS UNILATERAL 13 0.0009
547 URINARY TRACT INFECTION 157 0.0009
548 PULMONARY THROMBOSIS 10 0.0009
549 FLUSHING 93 0.0009
550 FEELING HOT 56 0.0009
551 DISABILITY 18 0.0009
552 RED BLOOD CELL COUNT DECREASED 26 0.0009
553 RENAL INJURY 27 0.0009
554 CATARACT 54 0.0009
555 BURSITIS 11 0.0009
556 LUNG INFILTRATION 8 0.0009
557 ADVERSE REACTION 12 0.0009
558 CONDITION AGGRAVATED 275 0.0009
559 DYSPNOEA EXERTIONAL 34 0.0009
560 INJECTION SITE BRUISING 72 0.0009
561 NO THERAPEUTIC RESPONSE 11 0.0009
562 RENAL DISORDER 42 0.0009
563 FUNGAL INFECTION 30 0.0009
564 RHINORRHOEA 58 0.0009
565 COLITIS 34 0.0009
566 HAEMOPTYSIS 25 0.0009
567 GLOSSODYNIA 20 0.0009
568 BRAIN FOG 14 0.0009
569 PRODUCT TASTE ABNORMAL 12 0.0009
570 HEMIPARESIS 15 0.0009
571 ACUTE RESPIRATORY FAILURE 17 0.0009
572 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 15 0.0009
573 RESPIRATORY TRACT INFECTION 23 0.0009
574 HEART RATE DECREASED 31 0.0009
575 BODY TEMPERATURE INCREASED 18 0.0009
576 COUGH 247 0.0009
577 GINGIVAL PAIN 7 0.0009
578 MUSCULOSKELETAL STIFFNESS 77 0.0009
579 ACUTE HEPATIC FAILURE 12 0.0009
580 JOINT STIFFNESS 23 0.0009
581 EMOTIONAL DISORDER 27 0.0009
582 VAGINAL HAEMORRHAGE 38 0.0009
583 RENAL FAILURE 116 0.0009
584 TOOTH LOSS 18 0.0009
585 FRUSTRATION TOLERANCE DECREASED 7 0.0009
586 DIVERTICULITIS 24 0.0009
587 PROCEDURAL PAIN 24 0.0009
588 EYE PRURITUS 29 0.0009
589 PERSONALITY CHANGE 8 0.0009
590 TRANSFUSION 9 0.0009
591 ADVERSE DRUG REACTION 77 0.0009
592 HEPATIC ENCEPHALOPATHY 8 0.0009
593 WEIGHT DECREASED 239 0.0009
594 DIARRHOEA HAEMORRHAGIC 8 0.0009
595 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 154 0.0009
596 DRUG EXPOSURE DURING PREGNANCY 29 0.0009
597 HALLUCINATION, VISUAL 18 0.0009
598 DEPRESSED MOOD 45 0.0009
599 ORAL PAIN 19 0.0008
600 PHOTOSENSITIVITY REACTION 14 0.0008
601 LABORATORY TEST ABNORMAL 25 0.0008
602 MOOD SWINGS 27 0.0008
603 THERAPEUTIC RESPONSE SHORTENED 28 0.0008
604 MOOD ALTERED 23 0.0008
605 HEMIPLEGIA 7 0.0008
606 PARALYSIS 12 0.0008
607 ANHEDONIA 22 0.0008
608 HYPERLIPIDAEMIA 10 0.0008
609 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
610 BLOOD PRESSURE FLUCTUATION 20 0.0008
611 DISORIENTATION 33 0.0008
612 TYPE 2 DIABETES MELLITUS 28 0.0008
613 OSTEOMYELITIS 15 0.0008
614 BLOOD PRESSURE DECREASED 55 0.0008
615 PERIPHERAL SWELLING 127 0.0008
616 THERAPY NON-RESPONDER 37 0.0008
617 DYSPNOEA 465 0.0008
618 NEUROPATHY PERIPHERAL 78 0.0008
619 PNEUMOTHORAX 13 0.0008
620 ORAL HERPES 16 0.0008
621 CARDIAC OPERATION 7 0.0008
622 ASTHMA 92 0.0008
623 VITREOUS FLOATERS 8 0.0008
624 UNRESPONSIVE TO STIMULI 21 0.0008
625 THERAPY CHANGE 8 0.0008
626 KNEE OPERATION 8 0.0008
627 PARANOIA 14 0.0008
628 HOSPICE CARE 8 0.0008
629 MOVEMENT DISORDER 26 0.0008
630 DEHYDRATION 108 0.0008
631 SYNCOPE 81 0.0008
632 GAIT INABILITY 27 0.0008
633 DRUG TOXICITY 11 0.0008
634 PHARYNGITIS 10 0.0008
635 OSTEOPOROSIS 33 0.0008
636 SKIN LESION 22 0.0008
637 MUSCULAR WEAKNESS 91 0.0008
638 INFLUENZA 89 0.0008
639 EYE INFECTION 9 0.0008
640 ARTHRALGIA 331 0.0008
641 GRIP STRENGTH DECREASED 7 0.0008
642 PRODUCT COMMUNICATION ISSUE 7 0.0008
643 COGNITIVE DISORDER 37 0.0008
644 BLOOD COUNT ABNORMAL 12 0.0008
645 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
646 CEREBROVASCULAR ACCIDENT 134 0.0008
647 EYE DISORDER 26 0.0008
648 TASTE DISORDER 16 0.0008
649 DIARRHOEA 509 0.0008
650 EYELID PTOSIS 8 0.0008
651 NASOPHARYNGITIS 145 0.0008
652 SUBARACHNOID HAEMORRHAGE 8 0.0008
653 MOTOR DYSFUNCTION 8 0.0008
654 ASTHENIA 295 0.0008
655 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
656 VISUAL ACUITY REDUCED 26 0.0008
657 LETHARGY 45 0.0008
658 GASTROINTESTINAL INFECTION 7 0.0008
659 SKIN DISORDER 26 0.0008
660 OROPHARYNGEAL DISCOMFORT 7 0.0008
661 EYELID OEDEMA 9 0.0008
662 POST PROCEDURAL HAEMORRHAGE 9 0.0008
663 CAESAREAN SECTION 9 0.0008
664 VENTRICULAR EXTRASYSTOLES 8 0.0008
665 PHARMACEUTICAL PRODUCT COMPLAINT 20 0.0008
666 DIPLOPIA 20 0.0008
667 SPLENOMEGALY 9 0.0008
668 PLATELET COUNT INCREASED 10 0.0008
669 WEIGHT FLUCTUATION 8 0.0008
670 PREMATURE BABY 23 0.0008
671 METRORRHAGIA 13 0.0008
672 AGEUSIA 19 0.0008
673 HAEMORRHAGE 79 0.0008
674 PRODUCT DISTRIBUTION ISSUE 7 0.0008
675 APATHY 11 0.0008
676 GASTROENTERITIS 11 0.0008
677 EATING DISORDER 16 0.0008
678 BREAST PAIN 8 0.0007
679 PRURITUS 288 0.0007
680 HERPES ZOSTER 43 0.0007
681 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 39 0.0007
682 DYSARTHRIA 28 0.0007
683 FEMUR FRACTURE 23 0.0007
684 ADRENAL INSUFFICIENCY 9 0.0007
685 DISCOMFORT 45 0.0007
686 SWELLING 69 0.0007
687 INFLAMMATION 38 0.0007
688 DECREASED APPETITE 171 0.0007
689 SKIN LACERATION 8 0.0007
690 LYMPHOCYTE COUNT DECREASED 13 0.0007
691 DYSURIA 27 0.0007
692 HALLUCINATION 55 0.0007
693 CORONARY ARTERY OCCLUSION 10 0.0007
694 WEIGHT INCREASED 163 0.0007
695 AFFECT LABILITY 7 0.0007
696 VISUAL IMPAIRMENT 90 0.0007
697 MOBILITY DECREASED 52 0.0007
698 MYALGIA 123 0.0007
699 VIRAL INFECTION 24 0.0007
700 PRODUCT DOSE OMISSION 47 0.0007
701 HIP ARTHROPLASTY 11 0.0007
702 SKIN FISSURES 14 0.0007
703 PELVIC PAIN 13 0.0007
704 PHARYNGEAL SWELLING 7 0.0007
705 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
706 CELLULITIS 36 0.0007
707 OEDEMA PERIPHERAL 87 0.0007
708 RENAL TUBULAR NECROSIS 7 0.0007
709 PRODUCTIVE COUGH 34 0.0007
710 PSYCHOTIC DISORDER 21 0.0007
711 STOMATITIS 43 0.0007
712 SINUS TACHYCARDIA 10 0.0007
713 HYPOPHAGIA 18 0.0007
714 ARTHROPATHY 39 0.0007
715 SCAB 8 0.0007
716 DRY EYE 35 0.0007
717 RASH PRURITIC 38 0.0007
718 LIVER FUNCTION TEST INCREASED 15 0.0007
719 ANOREXIA 9 0.0007
720 PALLOR 19 0.0007
721 BACTERIAL INFECTION 13 0.0007
722 NEOPLASM 8 0.0007
723 COVID-19 122 0.0007
724 FULL BLOOD COUNT DECREASED 14 0.0007
725 ADVERSE EVENT 64 0.0007
726 RESPIRATORY TRACT CONGESTION 11 0.0007
727 NODULE 9 0.0007
728 SEDATION 18 0.0007
729 BLINDNESS 28 0.0007
730 INTENTIONAL OVERDOSE 44 0.0007
731 MELAENA 15 0.0007
732 INCREASED APPETITE 13 0.0007
733 EMOTIONAL DISTRESS 82 0.0007
734 SEIZURE 78 0.0007
735 ATAXIA 8 0.0007
736 HAIR TEXTURE ABNORMAL 9 0.0007
737 STAPHYLOCOCCAL INFECTION 22 0.0007
738 PSORIATIC ARTHROPATHY 27 0.0007
739 DRUG ADMINISTERED AT INAPPROPRIATE SITE 7 0.0007
740 HEPATITIS C 8 0.0007
741 MENTAL IMPAIRMENT 16 0.0007
742 GINGIVAL BLEEDING 9 0.0007
743 BLOOD UREA INCREASED 11 0.0007
744 INJECTION SITE PRURITUS 44 0.0007
745 HAEMATOMA 17 0.0007
746 AGITATION 48 0.0007
747 INJECTION SITE ERYTHEMA 81 0.0007
748 CARDIAC DISORDER 61 0.0007
749 SMALL INTESTINAL OBSTRUCTION 8 0.0006
750 LYMPHADENOPATHY 23 0.0006
751 ATRIAL FIBRILLATION 63 0.0006
752 MENSTRUATION DELAYED 7 0.0006
753 WOUND 18 0.0006
754 TOOTH EXTRACTION 8 0.0006
755 HAEMOGLOBIN DECREASED 66 0.0006
756 ERYTHEMA 132 0.0006
757 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
758 BASAL CELL CARCINOMA 10 0.0006
759 BLOOD TEST ABNORMAL 9 0.0006
760 MATERNAL EXPOSURE DURING PREGNANCY 57 0.0006
761 INTESTINAL OBSTRUCTION 24 0.0006
762 BLOOD SODIUM DECREASED 12 0.0006
763 INJECTION SITE NODULE 7 0.0006
764 RESPIRATORY DISORDER 19 0.0006
765 MENSTRUATION IRREGULAR 17 0.0006
766 FOOT DEFORMITY 7 0.0006
767 MUSCULOSKELETAL DISORDER 12 0.0006
768 TACHYCARDIA 56 0.0006
769 HEPATIC FAILURE 19 0.0006
770 FREQUENT BOWEL MOVEMENTS 17 0.0006
771 PRODUCT STORAGE ERROR 55 0.0006
772 OBESITY 10 0.0006
773 OEDEMA 34 0.0006
774 ABSCESS 10 0.0006
775 ALOPECIA 123 0.0006
776 MALNUTRITION 7 0.0006
777 INTESTINAL PERFORATION 7 0.0006
778 THERAPY CESSATION 32 0.0006
779 HIP FRACTURE 20 0.0006
780 ERUCTATION 12 0.0006
781 PRODUCT DOSE OMISSION ISSUE 182 0.0006
782 DYSTONIA 12 0.0006
783 INJECTION SITE PAIN 189 0.0006
784 MYOCARDIAL ISCHAEMIA 7 0.0006
785 MENTAL STATUS CHANGES 17 0.0006
786 INJECTION SITE URTICARIA 15 0.0006
787 OCULAR HYPERAEMIA 29 0.0006
788 FLUID RETENTION 31 0.0006
789 WHEEZING 36 0.0006
790 PULMONARY CONGESTION 8 0.0006
791 BLISTER 34 0.0006
792 COLON CANCER 9 0.0006
793 SKIN CANCER 13 0.0006
794 URINARY RETENTION 20 0.0006
795 ABORTION SPONTANEOUS 24 0.0006
796 ANGINA PECTORIS 17 0.0006
797 SKIN EXFOLIATION 50 0.0006
798 CANDIDA INFECTION 10 0.0006
799 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
800 DEVICE FAILURE 9 0.0006
801 WHITE BLOOD CELL COUNT DECREASED 64 0.0006
802 OFF LABEL USE 514 0.0006
803 HAEMATURIA 20 0.0006
804 CONFUSIONAL STATE 94 0.0006
805 ACUTE KIDNEY INJURY 89 0.0006
806 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
807 EJECTION FRACTION DECREASED 9 0.0006
808 MYOCARDIAL INFARCTION 101 0.0006
809 IMPAIRED HEALING 19 0.0006
810 THERAPY PARTIAL RESPONDER 9 0.0006
811 NERVOUS SYSTEM DISORDER 18 0.0006
812 PULMONARY HYPERTENSION 12 0.0006
813 SCHIZOPHRENIA 7 0.0006
814 HYPOMAGNESAEMIA 8 0.0006
815 ORTHOSTATIC HYPOTENSION 10 0.0006
816 PRODUCT AVAILABILITY ISSUE 13 0.0006
817 HYPERCALCAEMIA 7 0.0006
818 ANAEMIA 108 0.0006
819 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
820 HAIR COLOUR CHANGES 7 0.0006
821 CORONARY ARTERY DISEASE 17 0.0006
822 SECRETION DISCHARGE 7 0.0006
823 SKIN BURNING SENSATION 40 0.0006
824 HYPOACUSIS 24 0.0006
825 ANOSMIA 8 0.0006
826 HYPERTHYROIDISM 8 0.0006
827 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
828 LIVER FUNCTION TEST ABNORMAL 16 0.0005
829 METASTASES TO BONE 9 0.0005
830 RHEUMATOID ARTHRITIS 62 0.0005
831 MYDRIASIS 7 0.0005
832 PSORIASIS 71 0.0005
833 PLEURAL EFFUSION 33 0.0005
834 RASH 236 0.0005
835 FOETAL EXPOSURE DURING PREGNANCY 44 0.0005
836 INJECTION SITE INDURATION 7 0.0005
837 NEOPLASM MALIGNANT 36 0.0005
838 JOINT SWELLING 65 0.0005
839 PNEUMONIA 174 0.0005
840 RASH PAPULAR 12 0.0005
841 APPLICATION SITE ERYTHEMA 14 0.0005
842 DEPENDENCE 29 0.0005
843 INFECTION 76 0.0005
844 KNEE ARTHROPLASTY 11 0.0005
845 INJECTION SITE RASH 16 0.0005
846 PULMONARY FIBROSIS 10 0.0005
847 DRUG DOSE OMISSION 86 0.0005
848 DYSKINESIA 21 0.0005
849 OXYGEN SATURATION DECREASED 29 0.0005
850 AMENORRHOEA 9 0.0005
851 ASPARTATE AMINOTRANSFERASE INCREASED 27 0.0005
852 HEPATITIS 13 0.0005
853 ISCHAEMIC STROKE 9 0.0005
854 HALLUCINATION, AUDITORY 8 0.0005
855 HEPATIC ENZYME INCREASED 34 0.0005
856 HYPOKALAEMIA 23 0.0005
857 DRUG INTOLERANCE 48 0.0005
858 RENAL FAILURE ACUTE 21 0.0005
859 SUICIDE ATTEMPT 30 0.0005
860 SNEEZING 11 0.0005
861 PANCREATITIS ACUTE 11 0.0005
862 INJECTION SITE MASS 18 0.0005
863 MANIA 8 0.0005
864 CARDIAC FAILURE CONGESTIVE 39 0.0005
865 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
866 INFUSION RELATED REACTION 32 0.0005
867 BLOOD GLUCOSE DECREASED 23 0.0005
868 DERMATITIS 10 0.0005
869 PERICARDIAL EFFUSION 11 0.0005
870 THERAPY INTERRUPTED 34 0.0005
871 ACNE 36 0.0005
872 FACE OEDEMA 8 0.0005
873 INJECTION SITE SWELLING 36 0.0005
874 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
875 EYE IRRITATION 27 0.0005
876 DRUG PRESCRIBING ERROR 9 0.0005
877 PYREXIA 162 0.0005
878 ERECTILE DYSFUNCTION 12 0.0005
879 DRY SKIN 62 0.0005
880 SKIN ULCER 12 0.0005
881 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
882 ANAPHYLACTIC REACTION 25 0.0005
883 DELUSION 7 0.0005
884 HYPOTENSION 90 0.0004
885 JAUNDICE 12 0.0004
886 PAIN OF SKIN 12 0.0004
887 RESPIRATORY FAILURE 32 0.0004
888 TREATMENT NONCOMPLIANCE 24 0.0004
889 INJECTION SITE WARMTH 9 0.0004
890 DEVICE DISLOCATION 19 0.0004
891 DRUG WITHDRAWAL SYNDROME 38 0.0004
892 BLOOD POTASSIUM INCREASED 7 0.0004
893 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
894 ANAPHYLACTIC SHOCK 11 0.0004
895 INJECTION SITE HAEMORRHAGE 34 0.0004
896 RASH GENERALISED 11 0.0004
897 EXPOSURE VIA SKIN CONTACT 11 0.0004
898 FRACTURE 8 0.0004
899 INTENTIONAL DOSE OMISSION 12 0.0004
900 ECZEMA 22 0.0004
901 RASH ERYTHEMATOUS 20 0.0004
902 PANCREATITIS 22 0.0004
903 SEPSIS 46 0.0004
904 CEREBRAL INFARCTION 10 0.0004
905 DEVICE DIFFICULT TO USE 27 0.0004
906 PULMONARY OEDEMA 18 0.0004
907 DEVICE MALFUNCTION 28 0.0004
908 DEMENTIA 11 0.0004
909 EPILEPSY 12 0.0004
910 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
911 LUNG DISORDER 19 0.0004
912 COMPLICATION OF DEVICE REMOVAL 7 0.0004
913 HOSPITALISATION 59 0.0004
914 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
915 ABNORMAL BEHAVIOUR 15 0.0004
916 ACCIDENTAL EXPOSURE TO PRODUCT 39 0.0004
917 DRUG INTERACTION 60 0.0004
918 INJECTION SITE REACTION 26 0.0004
919 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
920 LOCALISED INFECTION 9 0.0004
921 BLOOD GLUCOSE INCREASED 70 0.0004
922 PRODUCT ADHESION ISSUE 13 0.0004
923 PNEUMONIA ASPIRATION 9 0.0004
924 HEPATOTOXICITY 8 0.0004
925 ARRHYTHMIA 17 0.0004
926 TARDIVE DYSKINESIA 10 0.0004
927 BREAST CANCER 33 0.0004
928 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
929 PRESCRIBED UNDERDOSE 7 0.0004
930 PLATELET COUNT DECREASED 37 0.0003
931 RENAL IMPAIRMENT 29 0.0003
932 NEEDLE ISSUE 10 0.0003
933 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
934 HYPOXIA 12 0.0003
935 PRODUCT PREPARATION ERROR 7 0.0003
936 COMA 16 0.0003
937 MOUTH ULCERATION 7 0.0003
938 HYPERGLYCAEMIA 12 0.0003
939 RESPIRATORY ARREST 9 0.0003
940 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
941 DERMATITIS ATOPIC 17 0.0003
942 PRODUCT PRESCRIBING ISSUE 7 0.0003
943 AGGRESSION 16 0.0003
944 APPLICATION SITE PAIN 7 0.0003
945 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
946 NEOPLASM PROGRESSION 11 0.0003
947 LUNG NEOPLASM MALIGNANT 13 0.0003
948 COLITIS ULCERATIVE 14 0.0003
949 DRUG ABUSE 26 0.0003
950 RHABDOMYOLYSIS 13 0.0003
951 C-REACTIVE PROTEIN INCREASED 11 0.0003
952 BREAST CANCER FEMALE 8 0.0003
953 BLOOD CREATININE INCREASED 19 0.0003
954 DELIRIUM 10 0.0003
955 CARDIO-RESPIRATORY ARREST 12 0.0003
956 ENCEPHALOPATHY 7 0.0003
957 OSTEONECROSIS OF JAW 7 0.0003
958 DISEASE PROGRESSION 33 0.0003
959 CARDIAC ARREST 23 0.0003
960 DEVICE LEAKAGE 12 0.0003
961 INCORRECT DOSE ADMINISTERED BY DEVICE 7 0.0003
962 BRADYCARDIA 14 0.0003
963 BLOOD BILIRUBIN INCREASED 7 0.0003
964 DRUG DOSE OMISSION BY DEVICE 20 0.0003
965 RESPIRATORY DISTRESS 7 0.0003
966 METABOLIC ACIDOSIS 8 0.0002
967 NEUTROPHIL COUNT DECREASED 10 0.0002
968 SKIN IRRITATION 11 0.0002
969 ASCITES 7 0.0002
970 ACUTE MYOCARDIAL INFARCTION 7 0.0002
971 DEVICE ISSUE 21 0.0002
972 NO ADVERSE EVENT 41 0.0002
973 ANGIOEDEMA 10 0.0002
974 CARDIAC FAILURE 18 0.0002
975 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
976 DEVICE BREAKAGE 9 0.0002
977 TREATMENT FAILURE 18 0.0002
978 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
979 HEPATIC FUNCTION ABNORMAL 7 0.0002
980 COMPLETED SUICIDE 15 0.0002
981 PLASMA CELL MYELOMA 7 0.0002
982 HYPOGLYCAEMIA 8 0.0002
983 SEPTIC SHOCK 7 0.0002
984 TOXICITY TO VARIOUS AGENTS 26 0.0002
985 THROMBOCYTOPENIA 17 0.0002
986 NEUTROPENIA 20 0.0001
987 DEATH 124 0.0001
988 HYPONATRAEMIA 8 0.0001
989 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
990 PROSTATE CANCER 7 0.0001